期刊文献+

化痰降气胶囊对慢性阻塞性肺疾病模型大鼠作用机理的实验研究 被引量:4

Effect on the Level of TNF-α,LTB4 in Bronchoalveolar Lavage Fluid of Model Rats with Chronic Obstructive Pulmonary Disease by Huatanjiangqi Capsule
下载PDF
导出
摘要 目的:探讨化痰降气胶囊对慢性阻塞性肺疾病模型大鼠治疗作用的内在机理。方法:用2次气管内注入脂多糖(LPS)及熏香烟4周的复合刺激法建立大鼠肺气虚证模型。实验分为对照组、模型组和化痰降气胶囊组。并用酶联吸附实验(ELISA)方法,测定各组大鼠支气管灌洗液肿瘤坏死因子(TNF-α)、白三烯(LTB4)水平。结果:模型组支气管灌洗液TNF-,αLTB4水平较正常组显著升高(P<0.01);化痰降气胶囊组支气管灌洗液TNF-,αLTB4水平均明显降低(P<0.05)。结论:化痰降气胶囊可降低TNF-,αLTB4的含量,控制慢性炎症反应。 Objective: To observe the effects of Huatanjiangqi Capsule, a combination of traditional Chinese medical herbs on the changes of TNF-α, LTB4 in Bronchoalveolar Lavage Fluid (BALF) , in order to provide basis for the explanation of the mechanisms of Huatanjiangqi Capsule and discover it's pathophysiological characters. Methods: According to the principle of random, 36 Wistar rats (male) were divided into control group, model group and Huatanjiangqi Capsule group. Model group was established by intratracheal instillation of lipopolysaccharide (LPS) twice and exposed to cigarette smoke. TNF-α, LTB4 in bronehoalvolar lavage fluid of three groups were measured by ELISA. Results: TNF-α, LTB4 in bronchoalveolar lavage fluid of model group were significantly higher than in controlgroup (P 〈0.01), and the level of TNF-α, LTB4 of Huatanjiangqi Capsule group were lower than those of the model group ( P 〈 0. 05 ) . Conclusion: Huatanjiangqi Capsule could relieve the clinical symptoms and major injury of lung induced by super - excretion of inflame eytokine through dereasing the levels of TNF-α, LTB4 in the rats with Chronic Obstructive Pulmonary Disease.
出处 《成都中医药大学学报》 2007年第2期51-53,共3页 Journal of Chengdu University of Traditional Chinese Medicine
基金 国家中医药管理局新药开发资助项目(No.DZX031A)
关键词 化痰降气胶囊 慢性阻塞性肺疾病 肿瘤坏死因子Α 白三烯 Huatanjiangqi Capsule Chronic Obstructive Pulmonary Disease (COPD) Tumor Necrosis Factor alpha (TNF-α) Leukotrienes B4 (LTB4)
  • 相关文献

参考文献5

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2Jiang JX,Zhang XH,Li J,et al.Expression of TNF-αand relationship with endotoxin[J].Clin Med Science,1997,2:4-5.
  • 3Birke FW,Meade CJ,Anderskewilz R,et al.In vitro and in vivo pharmaco logical characterization of BIIL 284,a novel and potent leukotriene B4 receptor antagonist[J].J Pharmacol Exp Ther,2001,297:458-466.
  • 4Sampson SE,Costello JF,Sampson AP.The effect of inhaled leukot riene B4 in normal and in asthmatic subjects[J].Am J Respir Crit Care Med,1997,155(5):1789-1792.
  • 5Mitsunobu F,Mifune T,Hosaki Y,et al.Enhanced production of leukotrienes by peripheral leukocytes and specific IgE antibodies in pa tients with chronic obstructive pulmonary disease[J].JAllergy Clin Immunol,2001,107:492-498.

共引文献5102

同被引文献69

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部